首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1469793

全球诊断专用抗体市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Diagnostic Specialty Antibodies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 171 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球诊断专用抗体市场需求预计将从 2023 年的 280.1 亿美元达到 2032 年近 468.8 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.89%。

诊断专用抗体是在实验室中产生的蛋白质，旨在与特定目标分子（例如蛋白质、荷尔蒙或感染因子）结合，以用于诊断目的。这些抗体用于各种免疫测定技术，包括酵素连结免疫吸附测定 (ELISA)、蛋白质印迹和免疫组织化学，以检测和量化与疾病、感染和生理状况相关的生物标记。这些抗体是临床实验室、研究机构和医疗机构诊断疾病、监测治疗反应和进行医学研究的重要工具。它们在检测和识别生物样本中的特定抗原或分析物方面具有高特异性、灵敏度和重现性。

市场动态

传染病、自体免疫疾病和癌症的日益普及正在推动对先进诊断技术的需求，这些技术依赖特殊抗体来准确、及时地检测和监测疾病。特种抗体在各种诊断测定中发挥着至关重要的作用，包括酶联免疫吸附测定(ELISA)、免疫组织化学(IHC)、流式细胞仪和分子诊断，使医疗保健提供者能够以高灵敏度和特异性识别特定生物标记和病原体。此外，个人化医疗和标靶治疗的日益普及正在推动对伴随诊断的需求，这些诊断需要专门的抗体来进行患者分层、治疗选择和治疗监测。此外，抗体工程、生产方法和纯化技术的技术进步增强了特种抗体的性能、特异性和重现性，扩大了其在诊断测试中的应用。

此外，製药和生物技术公司不断增加对研发活动的投资，以开发新型生物标记、治疗标靶和诊断测定，推动了诊断专用抗体市场的成长。此外，对快速诊断测试、即时测试解决方案和利用特殊抗体的多重检测的需求不断增长，正在为市场扩张创造机会。此外，新兴经济体对早期疾病检测、预防性筛检计画和医疗基础设施发展的关注正在推动诊断实验室、医院和诊所采用诊断专用抗体。此外，诊断产业主要参与者之间的策略合作、伙伴关係和併购正在促进技术转移、产品创新和市场扩张。然而，诊断技术和替代测试方法的进步可能会在未来几年挑战诊断专用抗体市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球诊断专用抗体市场的每个细分市场进行了包容性评估。诊断专用抗体产业的成长和趋势为这项研究提供了整体方法。

市场区隔

诊断专用抗体市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按抗体类型

单株抗体
多株抗体抗体
重组多株抗体抗体

按申请

肝炎诊断
结核病诊断
登革热诊断
肿瘤诊断
爱滋病毒诊断
传染病诊断
其他的

按最终用户

医院
诊断实验室
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲诊断专用抗体市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。诊断专用抗体市场的主要参与者包括 Abcam plc、F. Hoffmann-La Roche Ltd.、Abbott Laboratories、Sanofi、Bio-Rad Laboratories, Inc.、Boehringer Ingelheim International GmbH、Agilent Technologies, Inc.、Aytu BioScience, Inc.本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：诊断专用抗体公司的竞争格局

诊断专用抗体市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Abcam plc

公司简介
公司收入
产品
最近的发展

F. Hoffmann-La Roche Ltd.

公司简介
公司收入
产品
最近的发展

Abbott Laboratories

公司简介
公司收入
产品
最近的发展

Sanofi

公司简介
公司收入
产品
最近的发展

Bio-Rad Laboratories Inc.

公司简介
公司收入
产品
最近的发展

Boehringer Ingelheim International GmbH

公司简介
公司收入
产品
最近的发展

Agilent Technologies Inc.

公司简介
公司收入
产品
最近的发展

Aytu BioScience Inc.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112114191

The global demand for Diagnostic Specialty Antibodies Market is presumed to reach the market size of nearly USD 46.88 Billion by 2032 from USD 28.01 Billion in 2023 with a CAGR of 5.89% under the study period 2024 - 2032.

Diagnostic specialty antibodies are proteins produced in the laboratory designed to bind to specific target molecules, such as proteins, hormones, or infectious agents, for diagnostic purposes. These antibodies are used in various immunoassay techniques, including enzyme-linked immunosorbent assays (ELISA), western blotting, and immunohistochemistry, to detect and quantify biomarkers associated with diseases, infections, and physiological conditions. These antibodies are crucial tools in clinical laboratories, research institutions, and healthcare settings for diagnosing diseases, monitoring treatment responses, and conducting medical research. They provide high specificity, sensitivity, and reproducibility in detecting and identifying specific antigens or analytes in biological samples.

MARKET DYNAMICS

The increasing prevalence of infectious diseases, autoimmune disorders, and cancer is driving the demand for advanced diagnostic techniques that rely on specialty antibodies for accurate and timely disease detection and monitoring. Specialty antibodies play a crucial role in various diagnostic assays, including enzyme-linked immunosorbent assays (ELISA), immunohistochemistry (IHC), flow cytometry, and molecular diagnostics, enabling healthcare providers to identify specific biomarkers and pathogens with high sensitivity and specificity. Moreover, the growing adoption of personalized medicine and targeted therapies is fuelling the demand for companion diagnostics that require specialized antibodies for patient stratification, treatment selection, and therapeutic monitoring. Additionally, technological advancements in antibody engineering, production methods, and purification techniques enhance specialty antibodies' performance, specificity, and reproducibility, expanding their applications in diagnostic testing.

Furthermore, pharmaceutical and biotechnology companies' increasing investments in research & development activities to develop novel biomarkers, therapeutic targets, and diagnostic assays drive diagnostic specialty antibodies market growth. Moreover, the rising demand for rapid diagnostic tests, point-of-care testing solutions, and multiplexed assays that utilize specialty antibodies is creating opportunities for market expansion. Furthermore, the focus on early disease detection, preventive screening programs, and healthcare infrastructure development in emerging economies is driving the adoption of diagnostic specialty antibodies in diagnostic laboratories, hospitals, and clinics. Furthermore, strategic collaborations, partnerships, and mergers & acquisitions among key players in the diagnostic industry are facilitating technology transfer, product innovation, and market expansion. However, advancements in diagnostic technologies and alternative testing methods may challenge the diagnostic specialty antibodies market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of diagnostic specialty antibodies. The growth and trends of diagnostic specialty antibodies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the diagnostic specialty antibodies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Antibody Type

Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Polyclonal Antibodies

By Application

Hepatitis Diagnostics
Tuberculosis Diagnostics
Dengue Diagnostics
Oncology Diagnostics
HIV Diagnostics
Infectious Disease Diagnostics
Others

By End-User

Hospitals
Diagnostic Laboratories
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Diagnostic Specialty Antibodies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Diagnostic Specialty Antibodies market include Abcam plc, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sanofi, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., Aytu BioScience, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DIAGNOSTIC SPECIALTY ANTIBODIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Antibody Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY ANTIBODY TYPE

5.1 Overview by Antibody Type
5.2 Historical and Forecast Data
5.3 Analysis by Antibody Type
5.4 Monoclonal Antibodies Historic and Forecast Sales by Regions
5.5 Polyclonal Antibodies Historic and Forecast Sales by Regions
5.6 Recombinant Polyclonal Antibodies Historic and Forecast Sales by Regions

6 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Hepatitis Diagnostics Historic and Forecast Sales by Regions
6.5 Tuberculosis Diagnostics Historic and Forecast Sales by Regions
6.6 Dengue Diagnostics Historic and Forecast Sales by Regions
6.7 Oncology Diagnostics Historic and Forecast Sales by Regions
6.8 HIV Diagnostics Historic and Forecast Sales by Regions
6.9 Infectious Disease Diagnostics Historic and Forecast Sales by Regions
6.10. Others Historic and Forecast Sales by Regions

7 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE DIAGNOSTIC SPECIALTY ANTIBODIES COMPANIES

9.1. Diagnostic Specialty Antibodies Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF DIAGNOSTIC SPECIALTY ANTIBODIES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Abcam plc
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. F. Hoffmann-La Roche Ltd.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Abbott Laboratories
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Sanofi
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Bio-Rad Laboratories Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Boehringer Ingelheim International GmbH
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Agilent Technologies Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Aytu BioScience Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments